553 related articles for article (PubMed ID: 21901982)
1. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
Singh KH; Shinde UA
Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
[TBL] [Abstract][Full Text] [Related]
2. Development and Evaluation of Novel Polymeric Nanoparticles of Brimonidine Tartrate.
Singh KH; Shinde UA
Curr Drug Deliv; 2010 Jul; 7(3):244-51. PubMed ID: 20497099
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
Aburahma MH; Mahmoud AA
AAPS PharmSciTech; 2011 Dec; 12(4):1335-47. PubMed ID: 21979886
[TBL] [Abstract][Full Text] [Related]
4. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
[TBL] [Abstract][Full Text] [Related]
5. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
Agnihotri SA; Aminabhavi TM
J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
[TBL] [Abstract][Full Text] [Related]
6. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
7. Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma.
Sharma PK; Chauhan MK
Curr Eye Res; 2021 Nov; 46(11):1703-1716. PubMed ID: 33844617
[No Abstract] [Full Text] [Related]
8. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
9. Monodisperse chitosan nanoparticles for mucosal drug delivery.
Zhang H; Oh M; Allen C; Kumacheva E
Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
[TBL] [Abstract][Full Text] [Related]
10. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
[TBL] [Abstract][Full Text] [Related]
11. Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.
Bhagav P; Upadhyay H; Chandran S
AAPS PharmSciTech; 2011 Dec; 12(4):1087-101. PubMed ID: 21879393
[TBL] [Abstract][Full Text] [Related]
12. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.
Kao HJ; Lin HR; Lo YL; Yu SP
J Pharm Pharmacol; 2006 Feb; 58(2):179-86. PubMed ID: 16451745
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
Cirpanli Y; Yerlikaya F; Ozturk K; Erdogar N; Launay M; Gegu C; Leturgez T; Bilensoy E; Calis S; Capan Y
Pharmazie; 2010 Dec; 65(12):867-70. PubMed ID: 21284254
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study.
Luo Y; Zhang B; Whent M; Yu LL; Wang Q
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):145-52. PubMed ID: 21440424
[TBL] [Abstract][Full Text] [Related]
15. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
16. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
17. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
[TBL] [Abstract][Full Text] [Related]
18. N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a novel delivery system for parathyroid hormone-related protein 1-34.
Zhao SH; Wu XT; Guo WC; Du YM; Yu L; Tang J
Int J Pharm; 2010 Jun; 393(1-2):268-72. PubMed ID: 20435115
[TBL] [Abstract][Full Text] [Related]
19. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.
Motwani SK; Chopra S; Talegaonkar S; Kohli K; Ahmad FJ; Khar RK
Eur J Pharm Biopharm; 2008 Mar; 68(3):513-25. PubMed ID: 17983737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
